Liven Pharma evaluates Hoover Pharma acquisition

MG News | January 05, 2026 at 04:04 PM GMT+05:00

0:00

January 05, 2026 (MLN): Liven Pharma Limited (PSX: LIVEN) is engaged in preliminary discussions with Hoover Pharma (Private) Limited regarding a potential acquisition.

The talks remain at an early, exploratory stage, with both sides assessing the viability and feasibility of a possible transaction.

No final decision has been taken so far, and the discussions are focused on evaluating strategic fit and potential benefits, according to the company’s statement on PSX revealed today.

Any potential transaction would remain subject to further evaluation, regulatory clearances, and the outcome of detailed due diligence.

The ongoing deliberations do not represent a definitive agreement or commitment at this point.

The disclosure aims to maintain transparency for the market and stakeholders as discussions continue.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	185,062.11 596.93M	1.45% 2653.87
ALLSHR	110,241.44 1,300.56M	1.17% 1270.51
KSE30	57,080.05 290.91M	1.66% 929.65
KMI30	260,701.15 256.48M	0.94% 2418.36
KMIALLSHR	70,664.60 691.62M	0.67% 473.37
BKTi	54,485.55 126.73M	3.66% 1921.34
OGTi	35,863.47 26.26M	-0.84% -302.02

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	93,870.00	94,885.00 93,480.00	-715.00 -0.76%
BRENT CRUDE	61.66	62.33 61.16	-0.10 -0.16%
RICHARDS BAY COAL MONTHLY	86.75	0.00 0.00	0.55 0.64%
ROTTERDAM COAL MONTHLY	99.50	99.50 98.00	1.65 1.69%
USD RBD PALM OLEIN	1,027.50	1,027.50 1,027.50	0.00 0.00%
CRUDE OIL - WTI	58.17	58.87 57.73	-0.15 -0.26%
SUGAR #11 WORLD	14.72	14.83 14.62	-0.01 -0.07%